Two-component binding
Describes binding between two components, such as PROTAC–target or PROTAC–E3. It constrains complex formation but does not encode ternary protein–protein contacts.
A ternary complex is necessary for many degraders, but its abundance alone does not predict target loss. Geometry, cooperativity, kinetics, ubiquitination competence, and cellular context all shape the outcome.
Does each component bind, and with what kinetics?
Is recruitment concentration-dependent and cooperative?
Which interface families are compatible with the data?
Does the target receive a degradation-compatible signal?
How deep, fast, selective, and reversible is degradation?
Cooperativity is not a single structural score. A useful analysis separates pose generation, interface stabilization, linker behavior, and design translation so computational results can be paired with the appropriate biophysical or cellular measurement.
Describes binding between two components, such as PROTAC–target or PROTAC–E3. It constrains complex formation but does not encode ternary protein–protein contacts.
How binding of one protein affects recruitment of the other. Its value is assay- and condition-dependent.
Association and dissociation rates determine how complexes form and turn over, independent of equilibrium affinity.
Whether the complex supports ubiquitination and degradation—geometry, lysines, E2/E3 activity, and proteasome access.
Positive cooperativity supports recruitment when one binary interaction is modest and may sharpen selectivity. Negative cooperativity can still degrade if concentrations, kinetics, and geometry are adequate. Interpret the value with care.
A bifunctional degrader links two binding events through a flexible molecule, creating many translational, rotational, and conformational degrees of freedom.
| Layer | Representative questions | Key controls |
|---|---|---|
| Binary engagement | Does each component bind, and with what kinetics? | Inactive analogs, competition, construct integrity, orthogonal format |
| Ternary formation | Is recruitment concentration-dependent and cooperative? | Binary partners, no-compound control, orientation reversal, concentration matrix |
| Structure and dynamics | Which interface families are compatible with the data? | Replicate simulations, alternative starts, mutagenesis, cross-link or structural restraints |
| Ubiquitination | Does the target receive a degradation-compatible ubiquitin signal? | Ligase dependence, lysine variants, E2/E3 controls, time course |
| Protein loss | How deep, fast, selective, and reversible is degradation? | Proteasome rescue, washout, global proteomics, transcript measurement |
| Function | Does phenotype follow depletion? | Resistant rescue, target-proximal biomarker, matched cytotoxicity controls |
At high concentrations, a bifunctional degrader can saturate target and ligase separately as binary complexes, reducing the fraction available for the ternary species. Absence of an obvious hook in a tested range does not prove binary saturation is irrelevant.
Concentration series should cover complex formation and degradation with matched timing, and free compound concentration is more informative than nominal dose when binding, aggregation, adsorption, or permeability are substantial.
Molecular dynamics assesses structural coherence, persistent contacts, linker preferences, and flexibility—but a low global RMSD does not establish productive ubiquitination.
Test ubiquitination geometry, lysine accessibility, complete ligase activity, permeability, and proteasome dependence.
Check missing cofactors, construct design, assay orientation, local concentrations, and kinetic rather than equilibrium effects.
Revisit starting-pose bias, protonation, linker parameters, missing domains, and whether the simulated pose is sufficiently populated.
Confirm the biological hypothesis, depletion threshold, target recovery, pathway redundancy, and assay timing.
Use early proteomics, transcript measurements, cytotoxicity controls, and genetic rescue to identify alternative mechanisms.
The authors demonstrated that favorable protein–protein contacts and linker folding create cooperative recognition in the VHL–MZ1–BRD4 complex—an instructive example, not a universal template for all ligases and targets.
The authors demonstrated catalytic, event-driven protein knockdown by PROTACs, establishing that substoichiometric degradation—rather than target occupancy—is the design goal that matters for potency.
The right interpretation depends on the assay and the question—these answers clarify what counts as evidence.
No. Positive cooperativity can support recruitment and selectivity, but systems with neutral or negative cooperativity may still degrade when concentrations, kinetics, geometry, and ubiquitination are favorable. Cooperativity is best used to interpret a defined system rather than as a universal pass–fail threshold.
No single format is universally authoritative. Immobilization, tags, construct boundaries, concentrations, mass transport, and fitting assumptions can affect results. Confidence increases when orthogonal assays agree and when the measured behavior explains mutational, structural, ubiquitination, and cellular degradation data.
There is no fixed number independent of system and question. Replicates should reveal whether conclusions are robust to starting pose and initial velocities. Convergence of one global metric is insufficient; pose populations, contacts, linker states, hydration, and uncertainty should be evaluated against the experimental decision being made.
Share the target, available ligands, preferred E3 systems, structural data, assays, and project constraints. CD ComputaBio will propose a fit-for-purpose interpretation plan. Related services: PROTAC Design and Development Service, Molecular Docking Service, Molecular Dynamics Simulation.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk